Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

56. Capino A C, Johnson P N, Williams P K, Anderson M, Bedwell S, Miller J L. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 148-155

57. Medina M, Schwier N C, Miller J L, Miller M M, Skrepnek G. Career skills assessment in a doctor of pharmacy curriculum. American Journal of Pharmacy Education. 2018; 82 : 6300

58. Autry M, Harrison K, White B, Miller J L. Liposomal amphotericin b-associated cardiac arrest: case report and literature review. Infectious Diseases in Clinical Practice/Wolters Kluwer Health. 2018; 26 : 326-330

59. Miller J L, Johnson P N, White B P, Neely S, Chaaban H, Kassa N, Welliver, Sr R C. Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit. The Pediatric infectious disease journal. 2018

60. Fox A, Skrepnek G H, Miller J L, Schwier N C, Ripley T L. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. American Journal of Cardiovascular Drugs . 2018

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.

Read More